Combination therapy with anti-IL-8 antibodies and anti-PD-1 antibodies for treating cancer

• 收藏
• 分享

专利权人:

Bristol-Myers Squibb Company

发明人:

CARLETON, Michael,FELTQUATE, David,DE HENAU, Olivier,REILLY, Timothy, Patrick,CHEN, Tian,FENG, Ye,HUANG, Shu-Pang, Ben,ZHOU, Ming,SURESH, Ramachandran

申请号：

AU2019207812

公开号：

AU2019207812A1

申请日:

2019.01.11

申请国别(地区):

AU

年份:

2020

代理人:

摘要：

Provided herein are methods for the clinical treatment of tumors (e.g., advanced solid tumors) in patients having certain levels of serum IL-8 using an anti-IL-8 antibody in combination with an anti-PD-1 antibody.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/